Group 1 - The company expects a significant increase in net profit for 2025, projecting a range of 1.38 billion to 1.48 billion yuan, representing a year-on-year growth of 30.96% to 40.44% [1] - The projected non-net profit for 2025 is estimated to be between 1.336 billion and 1.436 billion yuan, indicating a substantial year-on-year increase of 106.88% to 122.36% [1] - The company attributes its growth to enhanced market development and operational excellence initiatives, with a strong performance in its "3+1" core business segments, particularly in the fluorochemical sector [1] Group 2 - The chairman of the company outlined a five-year strategic plan (2026-2030) focusing on filling gaps in new chemical materials and ensuring supply of specialty products, aiming to become a leading provider of innovative advanced chemical material solutions [2] - The year 2026 is identified as a pivotal year for the company's new development phase and the foundation for "Technology Haohua" initiatives [2] - The chairman emphasized four key requirements for the company's development: commitment to mission, confidence in opportunities, determination to overcome challenges, and persistence in improving management efficiency [2]

Group 1 - The core investment logic in the chemical industry includes the impact of the US interest rate cut cycle and three additional optimistic factors [1] - The capacity expansion cycle that began in 2021 has ended, but overall demand in the chemical sector continues to grow, leading to an expected improvement in supply-demand dynamics and industry profitability [1] - China's complete industrial system, along with the associated capabilities of upstream and downstream industries and industrial agglomeration effects, enhances the global competitive advantage of the chemical industry, with many overseas capacities expected to shut down [1] - Policies tightening the approval of new chemical projects in terms of approval levels, energy-saving reviews, and carbon emission evaluations contribute to a reduction in industry competition [1]

Core Viewpoint - The recent strength in the non-ferrous and chemical sectors is attributed to price increases, which have become the main reason for the rise in stock prices in these sectors [1] Group 1: Non-Ferrous Metals Sector - The significant rise in metal prices has led to the realization of earnings in non-ferrous stocks, which have outperformed chemical stocks in terms of price increase [1] - The year 2025 is projected to be the first year of a major surge in the non-ferrous metals industry, indicating a long-term bullish outlook [1] Group 2: Chemical Sector - The chemical sector is also identified as a long-cycle industry, but its peak in the economic cycle is expected to occur later than that of the non-ferrous sector [1]

与此同时，海默科技高度重视人才团队与长期激励。公司已实施覆盖核心管理层、技术人员及业务骨干 的股权激励计划，有效凝聚内部共识，将员工利益与公司长远发展深度绑定，为战略执行提供重要保 障。 中证报中证网讯（记者 何昱璞）海默科技（300084）1月29日晚间发布2025年度业绩预告，预计全年归 属于上市公司股东的净利润亏损3750万元-7500万元，较2024年同期大幅收窄，减亏幅度达到 67.2%-83.6%。这一显著改善，反映了公司年内持续推进"提质增效、聚焦核心"战略取得实质性成效， 其经营基本面已发生积极转变。 公司业绩改善主要得益于核心主业盈利能力的持续释放。2025年上半年，海默科技多相流量计产品及相 关服务合计实现收入约1.1亿元，同比增长37%，其中，多相计量产品销售收入约5000万元，相关服务 收入约6000万元，同比分别增长49%和29%。公司研究院自主研发的油井测试管理系统（WTMS）于 2025年在阿曼油田实现商业化落地，成功完成公司数智技术出海的首次突破，当年已贡献近百万美元收 入，并已锁定未来两年的框架合同，为公司海外数字化业务的持续增长奠定坚实基础。该项目的成功， 验证了公司数字化 ...

牧原股份相关工作人员表示："公司已成功引入正大集团、丰益、中化香港、香港豫农国际、富达基 金、RBC、高毅、平安人寿保险、大家人寿、UBS AM等多家知名机构作为基石投资者，合计认购金额 约53.42亿港元。" 据了解，牧原股份已明确本次募资净额核心投向，围绕全球化战略推进与核心竞争力提升展开。60%募 集资金用于海外布局：约62.76亿港元将用于拓展海外商业版图，包括加强越南等东南亚国家在内的海 外市场开拓，完善全球供应链体系，推动海外收购、战略联盟等资本运作。这一布局与公司现有海外动 作形成呼应，此前牧原股份已在越南设立全资子公司，并与当地企业合作落地年出栏160万头的高科技 养殖项目，为海外市场拓展奠定基础。30%募集资金攻坚技术创新：约31.38亿港元将投入全产业链研 发创新工作，重点巩固公司在育种、智能养殖、营养管理及生物安全等核心领域的技术优势。10%募集 资金补充运营资金：约10.46亿港元将用作营运资金及一般企业用途，为日常经营运转、各项战略举措 落地提供充足的流动性支持。 早在2025年5月27日，牧原股份首次向香港联交所递交发行上市申请并刊发相关资料；同年11月27日， 公司收到中国证券监 ...

Core Viewpoint - Tianyu Digital Technology (002354) anticipates a net profit loss of 41 million to 59 million yuan for 2025 due to asset impairment provisions related to underperforming subsidiaries, although its main business has achieved profitability [1] Group 1: Financial Performance - The company plans to recognize impairment losses on certain assets, leading to the projected net profit loss [1] - Excluding the impairment factors, the main business has already turned profitable [1] - The scale of losses is expected to significantly narrow compared to the previous year, indicating improving profitability and operational quality [1] Group 2: Strategic Focus - Tianyu Digital is committed to advancing its three strategic pillars: digitalization, intelligence, and globalization [1] - The positive shift in performance is primarily attributed to the company's deep focus on AI applications [1] Group 3: AI and Technology Development - The company has developed a comprehensive AI marketing ecosystem, including the Behavision spatial intelligence model, which has been officially registered for generative AI services [1] - Tianyu Digital has established a matrix of one general model and four vertical models, enhancing its capabilities in AI marketing, embodied intelligence, AI electricity sales, and AI cross-border e-commerce [1] Group 4: Industry Applications - In AI marketing, the company’s SaaS platform automates the entire service chain for various industries, including internet, beauty, and 3C [2] - The BehavisionPro platform addresses industry challenges with its innovative "Assets—Behavior—Client" (ABC) architecture, accumulating over 150,000 3D data points and 650,000 multimodal data points [2] Group 5: Global Expansion - In November 2025, Tianyu Digital formed a strategic partnership with Seahub in Malaysia to commercialize its AI marketing and e-commerce capabilities in overseas markets [3] - The company aims to integrate its technological capabilities with diverse industry scenarios, enhancing its complete ecosystem from technology foundation to business closure [3]

Core Viewpoint - Green Alliance Technology (300369) forecasts a revenue of 2.4 billion to 2.6 billion yuan for 2025, representing a year-on-year growth of 1.78% to 10.26%, while net profit attributable to shareholders is expected to be between -60 million to -30 million yuan, indicating a reduction in losses by 83.55% to 91.78% [1] Group 1 - The company aims to enhance the alignment of technical products with customer needs and deepen the implementation of scenario-based solutions, which contributed to the expected revenue growth [1] - Green Alliance Technology is focusing on cost reduction and efficiency improvement by enhancing systematic operational capabilities, leading to a decrease in sales, management, and R&D expenses [1] - The company is strengthening cash flow management and optimizing process control to ensure positive operating cash flow [1] Group 2 - In 2025, the company plans to increase investments in the AI sector, particularly in AI-enabled security operations across various industries such as telecommunications, finance, energy, education, and government [1] - The company aims to achieve an 80% independent takeover target for AI in core scenarios of detection response and exposure management, marking a transition from "human-machine collaboration" to "AI-led, expert supervision" in its security operations business [1]

Core Viewpoint - The National Taxation Administration of China held a report meeting themed "The Light of Role Models, The Song of Progress," recognizing ten exemplary tax officials to inspire and motivate tax personnel across the country [1] Group 1: Recognition of Exemplary Tax Officials - The event featured the awarding of certificates to ten outstanding tax officials, including Lü Yugang, Li Jing, and others, who have demonstrated exceptional dedication and service in various capacities [1] - These officials have contributed significantly to tax services, showcasing commitment through various initiatives, such as enhancing taxpayer services and implementing data-driven tax management [1] Group 2: Promotion of Taxation Spirit - The National Taxation Administration emphasized the importance of learning from these exemplary figures to foster a competitive and progressive atmosphere within the tax system [1] - The initiative aims to encourage tax officials to adopt a more enthusiastic, pragmatic, and effective approach in their work, contributing to the modernization of China's tax practices during the 14th Five-Year Plan period [1]

此外，商务拓展（BD）收入增长也是诺诚健华2025年营业收入快速增长的另一个重要因素。2025年， 诺诚健华持续推进全球化进程，全年达成两项BD交易。2025年1月，诺诚健华与Prolium Bioscience Inc. 关于CD20×CD3双特异性抗体ICP-B02 （CM355）达成许可合作。2025年10月，诺诚健华与Zenas BioPharma, Inc.达成关于奥布替尼及两项临床前分子相关权益的授权许可协议。（王珞） 诺诚健华1月29日发布2025年年度业绩预告。公告显示，诺诚健华预计2025年实现营收23.65亿元，与上 年同期相比增长约134%。与此同时，公司预计2025年首次实现扭亏为盈，归母净利润为6.3亿元左右， 较上年同期归母净利润增加约10.74亿元。 转自：中国证券报·中证网 2025年，诺诚健华药品收入持续快速增长。2025年4月，奥布替尼获批新适应症，用于一线治疗慢性淋 巴细胞白血病（CLL）/小淋巴细胞淋巴瘤（SLL）成人患者。除奥布替尼外，2025年5月，坦昔妥单抗 联合来那度胺治疗不适合ASCT条件的复发/难治性弥漫性大B细胞淋巴瘤（r/r DLBCL）成人患者的上市 ...

Core Viewpoint - The company, Berry Genomics, anticipates a net loss for 2025, projecting a net profit attributable to shareholders between -250 million to -170 million yuan, compared to -192 million yuan in 2024 [1][2] Financial Performance - The company expects a net loss of 165 million to 245 million yuan after deducting non-recurring items for 2025, with a corresponding loss of 192 million yuan in 2024 [1] - Revenue has declined during the reporting period, although operating cash flow remains stable [1] Asset Management - Berry Genomics has conducted a comprehensive review and impairment testing of its assets based on prudence, which has impacted the current net profit [1] - The company has increased its R&D investment, which has led to higher expenses affecting the current net profit [1] Business Focus - The main business of Berry Genomics includes gene testing services and related equipment, focusing on reproductive health, genetic disease testing, and technology services [1] - The company aims to integrate gene testing technology with artificial intelligence algorithms to drive innovation in precision medicine, which is expected to generate revenue [2] Market Position - The newborn gene screening business is progressing as expected, which is anticipated to positively impact the company's business layout in reproductive health [2] - From 2021 to 2024 and the first three quarters of 2025, the company's net profit, net profit attributable to shareholders, and net profit after deducting non-recurring items have consistently been negative [2] Shareholder Issues - Recently, the controlling shareholder, Gao Yang, faced a default in stock pledge repurchase business, resulting in the forced execution of 3.5352 million shares, accounting for 0.999% of the company's total share capital [2]